Mechanism of Initiation and Progression of Glomerular Sclerosis and its Prevention in Hypertensive Kidneys
Mechanism of Initiation and Progression of Glomerular Sclerosis and its Prevention in Hypertensive Kidneys
批准号:
10670998
负责人:
TAKABATAKE Toshikazu
金额:
$1.73万
依托单位国家:
日本
项目类别:
Grant-in-Aid for Scientific Research (C)
财政年份:
1998
资助国家:
日本
项目状态:
已结题
起止时间:
1998 至 1999
中文摘要
点击翻译按钮获取中文摘要
英文摘要
Glomerular hemodynamics and tubuloglomerular feedback (TGF) mechanism were evaluated in anesthetized 9-25-week-old spontaneously hypertensive rats (SHR) and Wistar-Kyoto rats (WKY).Micropuncture experiments revealed that the maximal reduction of proximal stop-flow pressure (SEP), an index of intraglomerular pressure (Pgc), induced by loop of Henle perfusion was significantly larger in SHR than in WKY at 9-10 week old (33 vs. 22% of SFP at zero perfusion), indicating the hyperactivity of TGF in SHR. Systemic blood pressure (SBP) was higher, renal vascular resistance (RVR) was greater, and renal plasma flow (RPF) was less in SHR than in WKY. At 14-16 week old, however, the difference of SFP reduction was not observed (28 vs. 28%). SFP at zero perfusion was comparable among 9-10, 14-16, and 23-25-week-old SHR. Adenosine A1 receptor antagonist (FK838, I.v.) suppressed TGF and increased SFP at zero perfusion in SHR, thus induced an upwards shift of the TGF curve. FK838 increased GFR, RPF, and FENa, while SBP remained unaltered. Adrenomedullin (I.v.) suppressed TGF in SHR to the level in WKY ; the SFP at zero perfusion was unchanged and the tubular flow rate at the steady state increased, indicating a rightwards shift of the TGF curve. SBP and RVR were decreased, GFR unchanged, and RPF and FENa increased by adrenomedullin.In conclusion, TGF is activated in SHR at 9-10 week old, and Pgc remains normal in 9-25-week-old SHR. A1 antagonist or adrenomedullin suppresses TGF. The former induces the glomerular hypertension and hyperfiltration through the afferent arteriolar vasodilatation. The latter, however, keeps Pgc normal through both afferent and efferent vasodilatation. Adrenomedullin normalizes TGF, induces natriuresis, and lowers SBP, and thereby may prevent the initiation and/or the progression of the glomerular sclerosis in SHR.
期刊论文(8)
专著(0)
科研奖励(0)
会议论文
登录
查看更多内容
M. Kawabata, T. Ogawa, T. Takabatake: "Effects of lemildipine, a new calcium channel blocker, on renal microcirculation in SHR"Hypertension Research. 21. 121-126 (1998)
M. Kawabata、T. Okawa、T. Takabatake:“雷米地平(一种新型钙通道阻滞剂)对 SHR 肾微循环的影响”高血压研究。
DOI:
--
发表时间:
期刊:
影响因子:
--
作者:
[]
通讯作者:
M. Kawabata, T. Ogawa, T. Takabatake: "Control of rat glomerular microcirculation by juxtaglomerular adenosine A1 receptors"Kidney International. 54 (Suppl 67). S228-S230 (1998)
M. Kawabata、T. Okawa、T. Takabatake:“肾小球旁腺苷 A1 受体控制大鼠肾小球微循环”肾脏国际。
DOI:
--
发表时间:
期刊:
影响因子:
--
作者:
[]
通讯作者:
M. Kawabata, T. Ogawa, T. Takabatake: "Effects of lemildipine, a new calcium channel blocker, or renal microcirculation in SHR"Hypertension Research. 21. 121-126 (1998)
M. Kawabata、T. Okawa、T. Takabatake:“雷米地平(一种新型钙通道阻滞剂)或肾微循环对 SHR 的影响”高血压研究。
DOI:
--
发表时间:
期刊:
影响因子:
--
作者:
[]
通讯作者:
DOI:
--
发表时间:
期刊:
影响因子:
--
作者:
[]
通讯作者:
M. Kawabata, T. Ogawa, T. Takabatake: "Control of rat glomerular microcirculation by juxtaglomerular adenosine A1 receptors"Kidney International. 54 (Suppl 67). S-228-S-230 (1998)
M. Kawabata、T. Okawa、T. Takabatake:“肾小球旁腺苷 A1 受体控制大鼠肾小球微循环”肾脏国际。
DOI:
--
发表时间:
期刊:
影响因子:
--
作者:
[]
通讯作者:
共 6 条
国内基金
海外基金
金线莲苷在肝窦阻塞综合征中对肝窦内皮细胞的保护作用及机制
-
批准号:JCZRLH202500091
-
项目类别:省市级项目
-
资助金额:--
-
批准年份:2025
-
负责人:
-
依托单位: